1. Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA 2. Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
RNA viruses cause a multitude of human diseases, including several pandemic events in the past century. Upon viral invasion, the innate immune system responds rapidly and plays a key role in activating the adaptive immune system. In the innate immune system, the interactions between pathogen-associated molecular patterns and host pattern recognition receptors activate multiple signaling pathways in immune cells and induce the production of pro-inflammatory cytokines and interferons to elicit antiviral responses. Macrophages, dendritic cells, and natural killer cells are the principal innate immune components that exert antiviral activities. In this review, the current understanding of innate immunity contributing to the restriction of RNA viral infections was briefly summarized. Besides the main role of immune cells in combating viral infection, the intercellular transfer of pathogen and host-derived materials and their epigenetic and metabolic interactions associated with innate immunity was discussed. This knowledge provides an enhanced understanding of the innate immune response to RNA viral infections in general and aids in the preparation for the existing and next emerging viral infections.
P Broz, DM Monack. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol 2013; 13(8): 551–565 https://doi.org/10.1038/nri3479
pmid: 23846113
S Jensen, AR Thomsen. Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J Virol 2012; 86(6): 2900–2910 https://doi.org/10.1128/JVI.05738-11
pmid: 22258243
O de Bouteiller, E Merck, UA Hasan, S Hubac, B Benguigui, G Trinchieri, EE Bates, C Caux. Recognition of double-stranded RNA by human Toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem 2005; 280(46): 38133–38145 https://doi.org/10.1074/jbc.M507163200
pmid: 16144834
7
SS Diebold, T Kaisho, H Hemmi, S Akira, C Reis e Sousa. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303(5663): 1529–1531 https://doi.org/10.1126/science.1093616
pmid: 14976261
8
F Heil, H Hemmi, H Hochrein, F Ampenberger, C Kirschning, S Akira, G Lipford, H Wagner, S Bauer. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 2004; 303(5663): 1526–1529 https://doi.org/10.1126/science.1093620
pmid: 14976262
A Krug, AR French, W Barchet, JA Fischer, A Dzionek, JT Pingel, MM Orihuela, S Akira, WM Yokoyama, M Colonna. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004; 21(1): 107–119 https://doi.org/10.1016/j.immuni.2004.06.007
pmid: 15345224
11
JH Lai, MY Wang, CY Huang, CH Wu, LF Hung, CY Yang, PY Ke, SF Luo, SJ Liu, LJ Ho. Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells. EMBO Rep 2018; 19(8): 19 https://doi.org/10.15252/embr.201846182
pmid: 29880709
K Takahasi, M Yoneyama, T Nishihori, R Hirai, H Kumeta, R Narita, M Gale Jr, F Inagaki, T Fujita. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 2008; 29(4): 428–440 https://doi.org/10.1016/j.molcel.2007.11.028
pmid: 18242112
14
JJ Chiang, KMJ Sparrer, M van Gent, C Lässig, T Huang, N Osterrieder, KP Hopfner, MU Gack. Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat Immunol 2018; 19(1): 53–62 https://doi.org/10.1038/s41590-017-0005-y
pmid: 29180807
15
M Jiang, S Zhang, Z Yang, H Lin, J Zhu, L Liu, W Wang, S Liu, W Liu, Y Ma, L Zhang, X. CaoSelf-recognition of an inducible host lncRNA by RIG-I feedback restricts innate immune response. Cell 2018; 173: 906–919.e13 PMID: 29706547 https://doi.org/DOI: 10.1016/j.cell.2018.03.064
16
Y Zhao, X Ye, W Dunker, Y Song, J Karijolich. RIG-I like receptor sensing of host RNAs facilitates the cell-intrinsic immune response to KSHV infection. Nat Commun 2018; 9(1): 4841 https://doi.org/10.1038/s41467-018-07314-7
pmid: 30451863
17
F Hou, L Sun, H Zheng, B Skaug, QX Jiang, ZJ Chen. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011; 146(3): 448–461 https://doi.org/10.1016/j.cell.2011.06.041
pmid: 21782231
18
KN Son, Z Liang, HL Lipton. Double-stranded RNA is detected by immunofluorescence analysis in RNA and DNA virus infections, including those by negative-stranded RNA viruses. J Virol 2015; 89(18): 9383–9392 https://doi.org/10.1128/JVI.01299-15
pmid: 26136565
19
RY Sanchez David, C Combredet, V Najburg, GA Millot, G Beauclair, B Schwikowski, T Léger, JM Camadro, Y Jacob, J Bellalou, N Jouvenet, F Tangy, AV Komarova. LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses. Sci Signal 2019; 12(601): eaar3993 https://doi.org/10.1126/scisignal.aar3993
pmid: 31575732
20
A Komuro, CM Horvath. RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J Virol 2006; 80(24): 12332–12342 https://doi.org/10.1128/JVI.01325-06
pmid: 17020950
21
T Saito, R Hirai, YM Loo, D Owen, CL Johnson, SC Sinha, S Akira, T Fujita, M Gale Jr. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci USA 2007; 104(2): 582–587 https://doi.org/10.1073/pnas.0606699104
pmid: 17190814
JL Miller, BJ de Wet, L Martinez-Pomares, CM Radcliffe, RA Dwek, PM Rudd, S Gordon. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 2008; 4(2): e17 https://doi.org/10.1371/journal.ppat.0040017
pmid: 18266465
S Carpenter, EP Ricci, BC Mercier, MJ Moore, KA Fitzgerald. Post-transcriptional regulation of gene expression in innate immunity. Nat Rev Immunol 2014; 14(6): 361–376 https://doi.org/10.1038/nri3682
pmid: 24854588
27
X Cao. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol 2016; 16(1): 35–50 https://doi.org/10.1038/nri.2015.8
pmid: 26711677
28
AJ Tong, X Liu, BJ Thomas, MM Lissner, MR Baker, MD Senagolage, AL Allred, GD Barish, ST Smale. A stringent systems approach uncovers gene-specific mechanisms regulating inflammation. Cell 2016; 165(1): 165–179 https://doi.org/10.1016/j.cell.2016.01.020
pmid: 26924576
29
K Honda, T Taniguchi. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006; 6(9): 644–658 https://doi.org/10.1038/nri1900
pmid: 16932750
30
K Högner, T Wolff, S Pleschka, S Plog, AD Gruber, U Kalinke, HD Walmrath, J Bodner, S Gattenlöhner, P Lewe-Schlosser, M Matrosovich, W Seeger, J Lohmeyer, S Herold. Macrophage-expressed IFN-b contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog 2013; 9(2): e1003188 https://doi.org/10.1371/journal.ppat.1003188
pmid: 23468627
31
C Kallfass, S Lienenklaus, S Weiss, P Staeheli. Visualizing the β interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. J Virol 2013; 87(12): 6925–6930 https://doi.org/10.1128/JVI.00283-13
pmid: 23576514
32
NA Jewell, N Vaghefi, SE Mertz, P Akter, RS Peebles Jr, LO Bakaletz, RK Durbin, E Flaño, JE Durbin. Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol 2007; 81(18): 9790–9800 https://doi.org/10.1128/JVI.00530-07
pmid: 17626092
33
J Pothlichet, I Meunier, BK Davis, JP Ting, E Skamene, V von Messling, SM Vidal. Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathog 2013; 9(4): e1003256 https://doi.org/10.1371/journal.ppat.1003256
pmid: 23592984
34
IC Allen, MA Scull, CB Moore, EK Holl, E McElvania-TeKippe, DJ Taxman, EH Guthrie, RJ Pickles, JP Ting. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009; 30(4): 556–565 https://doi.org/10.1016/j.immuni.2009.02.005
pmid: 19362020
35
SM Man, TD Kanneganti. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol 2016; 16(1): 7–21 https://doi.org/10.1038/nri.2015.7
pmid: 26655628
CS Shi, NR Nabar, NN Huang, JH Kehrl. SARS-coronavirus open reading frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov 2019; 5(1): 101 https://doi.org/10.1038/s41420-019-0181-7
pmid: 31231549
38
HH Wong, TS Fung, S Fang, M Huang, MT Le, DX Liu. Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3. Virology 2018; 515: 165–175 https://doi.org/10.1016/j.virol.2017.12.028
pmid: 29294448
39
L Sun, J Wu, F Du, X Chen, ZJ Chen. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013; 339(6121): 786–791 https://doi.org/10.1126/science.1232458
pmid: 23258413
40
J Wu, L Sun, X Chen, F Du, H Shi, C Chen, ZJ Chen. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013; 339(6121): 826–830 https://doi.org/10.1126/science.1229963
pmid: 23258412
41
Y Zheng, Q Liu, Y Wu, L Ma, Z Zhang, T Liu, S Jin, Y She, YP Li, J Cui. Zika virus elicits inflammation to evade antiviral response by cleaving cGAS via NS1-caspase-1 axis. EMBO J 2018; 37(18): e99347 https://doi.org/10.15252/embj.201899347
pmid: 30065070
42
K Farhat, S Riekenberg, H Heine, J Debarry, R Lang, J Mages, U Buwitt-Beckmann, K Röschmann, G Jung, KH Wiesmüller, AJ Ulmer. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol 2008; 83(3): 692–701 https://doi.org/10.1189/jlb.0807586
pmid: 18056480
43
MS Jin, SE Kim, JY Heo, ME Lee, HM Kim, SG Paik, H Lee, JO Lee. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007; 130(6): 1071–1082 https://doi.org/10.1016/j.cell.2007.09.008
pmid: 17889651
44
K Hoshino, O Takeuchi, T Kawai, H Sanjo, T Ogawa, Y Takeda, K Takeda, S Akira. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162(7): 3749–3752
pmid: 10201887
45
R Schwandner, R Dziarski, H Wesche, M Rothe, CJ Kirschning. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274(25): 17406–17409 https://doi.org/10.1074/jbc.274.25.17406
pmid: 10364168
46
F Hayashi, KD Smith, A Ozinsky, TR Hawn, EC Yi, DR Goodlett, JK Eng, S Akira, DM Underhill, A Aderem. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410(6832): 1099–1103 https://doi.org/10.1038/35074106
pmid: 11323673
FO Martinez, S Gordon. The evolution of our understanding of macrophages and translation of findings toward the clinic. Expert Rev Clin Immunol 2015; 11(1): 5–13 https://doi.org/10.1586/1744666X.2015.985658
pmid: 25434688
F Ginhoux, S Jung. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol 2014; 14(6): 392–404 https://doi.org/10.1038/nri3671
pmid: 24854589
51
J Xue, SV Schmidt, J Sander, A Draffehn, W Krebs, I Quester, D De Nardo, TD Gohel, M Emde, L Schmidleithner, H Ganesan, A Nino-Castro, MR Mallmann, L Labzin, H Theis, M Kraut, M Beyer, E Latz, TC Freeman, T Ulas, JL Schultze. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014; 40(2): 274–288 https://doi.org/10.1016/j.immuni.2014.01.006
pmid: 24530056
52
PJ Murray, JE Allen, SK Biswas, EA Fisher, DW Gilroy, S Goerdt, S Gordon, JA Hamilton, LB Ivashkiv, T Lawrence, M Locati, A Mantovani, FO Martinez, JL Mege, DM Mosser, G Natoli, JP Saeij, JL Schultze, KA Shirey, A Sica, J Suttles, I Udalova, JA van Ginderachter, SN Vogel, TA Wynn. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014; 41(1): 14–20 https://doi.org/10.1016/j.immuni.2014.06.008
pmid: 25035950
53
A Domínguez-Soto, M de las Casas-Engel, R Bragado, J Medina-Echeverz, L Aragoneses-Fenoll, E Martín-Gayo, N van Rooijen, P Berraondo, ML Toribio, MA Moro, I Cuartero, A Castrillo, D Sancho, C Sánchez-Torres, P Bruhns, S Sánchez-Ramón, AL Corbí. Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization. J Immunol 2014; 193(10): 5181–5189 https://doi.org/10.4049/jimmunol.1303375
pmid: 25326025
54
FO Martinez, S Gordon. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014; 6: 13 https://doi.org/10.12703/P6-13
pmid: 24669294
55
HH Gad, C Dellgren, OJ Hamming, S Vends, SR Paludan, R Hartmann. Interferon-λ is functionally an interferon but structurally related to the interleukin-10 family. J Biol Chem 2009; 284(31): 20869–20875 https://doi.org/10.1074/jbc.M109.002923
pmid: 19457860
56
Y Sang, W Brichalli, RR Rowland, F Blecha. Genome-wide analysis of antiviral signature genes in porcine macrophages at different activation statuses. PLoS One 2014; 9(2): e87613 https://doi.org/10.1371/journal.pone.0087613
pmid: 24505295
F McNab, K Mayer-Barber, A Sher, A Wack, A O’Garra. Type I interferons in infectious disease. Nat Rev Immunol 2015; 15(2): 87–103 doi:10.1038/nri3787
pmid: 25614319
X Zhao, J Dai, X Xiao, L Wu, J Zeng, J Sheng, J Su, X Chen, G Wang, K Li. PI3K/Akt signaling pathway modulates influenza virus induced mouse alveolar macrophage polarization to M1/M2b. PLoS One 2014; 9(8): e104506 https://doi.org/10.1371/journal.pone.0104506
pmid: 25105760
62
Y Yang, R Zhang, F Xia, T Zou, A Huang, S Xiong, J Zhang. LPS converts Gr-1+CD115+ myeloid-derived suppressor cells from M2 to M1 via P38 MAPK. Exp Cell Res 2013; 319(12): 1774–1783 https://doi.org/10.1016/j.yexcr.2013.05.007
pmid: 23701951
63
JM González-Navajas, J Lee, M David, E Raz. Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012; 12(2): 125–135 https://doi.org/10.1038/nri3133
pmid: 22222875
64
M Jaume, MS Yip, CY Cheung, HL Leung, PH Li, F Kien, I Dutry, B Callendret, N Escriou, R Altmeyer, B Nal, M Daëron, R Bruzzone, JS Peiris. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcgR pathway. J Virol 2011; 85(20): 10582–10597 https://doi.org/10.1128/JVI.00671-11
pmid: 21775467
65
MS Yip, NH Leung, CY Cheung, PH Li, HH Lee, M Daëron, JS Peiris, R Bruzzone, M Jaume. Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus. Virol J 2014; 11(1): 82 https://doi.org/10.1186/1743-422X-11-82
pmid: 24885320
66
J Zhao, J Zhao, N Van Rooijen, S Perlman. Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice. PLoS Pathog 2009; 5(10): e1000636 https://doi.org/10.1371/journal.ppat.1000636
pmid: 19851468
67
Y Tatano, T Shimizu, H Tomioka. Unique macrophages different from M1/M2 macrophages inhibit T cell mitogenesis while upregulating Th17 polarization. Sci Rep 2014; 4(1): 4146 https://doi.org/10.1038/srep04146
pmid: 24553452
68
I Darwish, S Mubareka, WC Liles. Immunomodulatory therapy for severe influenza. Expert Rev Anti Infect Ther 2011; 9(7): 807–822 https://doi.org/10.1586/eri.11.56
pmid: 21810053
69
RM Boehler, R Kuo, S Shin, AG Goodman, MA Pilecki, RM Gower, JN Leonard, LD Shea. Lentivirus delivery of IL-10 to promote and sustain macrophage polarization towards an anti-inflammatory phenotype. Biotechnol Bioeng 2014; 111(6): 1210–1221 https://doi.org/10.1002/bit.25175
pmid: 24375008
70
K Richter, G Perriard, R Behrendt, RA Schwendener, V Sexl, R Dunn, M Kamanaka, RA Flavell, A Roers, A Oxenius. Macrophage and T cell produced IL-10 promotes viral chronicity. PLoS Pathog 2013; 9(11): e1003735 https://doi.org/10.1371/journal.ppat.1003735
pmid: 24244162
71
MT Zdrenghea, H Makrinioti, A Muresan, SL Johnston, LA Stanciu. The role of macrophage IL-10/innate IFN interplay during virus-induced asthma. Rev Med Virol 2015; 25(1): 33–49 https://doi.org/10.1002/rmv.1817
pmid: 25430775
72
P Ouyang, K Rakus, SJ van Beurden, AH Westphal, AJ Davison, D Gatherer, AF Vanderplasschen. IL-10 encoded by viruses: a remarkable example of independent acquisition of a cellular gene by viruses and its subsequent evolution in the viral genome. J Gen Virol 2014; 95(Pt 2): 245–262 https://doi.org/10.1099/vir.0.058966-0
pmid: 24225498
73
EB Wilson, DG Brooks. The role of IL-10 in regulating immunity to persistent viral infections. Curr Top Microbiol Immunol 2011; 350: 39–65 https://doi.org/10.1007/82_2010_96
pmid: 20703965
74
DJ Perkins, SK Polumuri, ME Pennini, W Lai, P Xie, SN Vogel. Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production. PLoS Pathog 2013; 9(7): e1003479 https://doi.org/10.1371/journal.ppat.1003479
pmid: 23853595
75
MC Patel, KA Shirey, LM Pletneva, MS Boukhvalova, A Garzino-Demo, SN Vogel, JC Blanco. Novel drugs targeting Toll-like receptors for antiviral therapy. Future Virol 2014; 9(9): 811–829 https://doi.org/10.2217/fvl.14.70
pmid: 25620999
76
B Zhang, B Chassaing, Z Shi, R Uchiyama, Z Zhang, TL Denning, SE Crawford, AJ Pruijssers, JA Iskarpatyoti, MK Estes, TS Dermody, W Ouyang, IR Williams, M Vijay-Kumar, AT Gewirtz. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18. Science 2014; 346(6211): 861–865 https://doi.org/10.1126/science.1256999
pmid: 25395539
L Ziegler-Heitbrock, P Ancuta, S Crowe, M Dalod, V Grau, DN Hart, PJ Leenen, YJ Liu, G MacPherson, GJ Randolph, J Scherberich, J Schmitz, K Shortman, S Sozzani, H Strobl, M Zembala, JM Austyn, MB Lutz. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116(16): e74–e80 https://doi.org/10.1182/blood-2010-02-258558
pmid: 20628149
81
A Moretta. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002; 2(12): 957–964 https://doi.org/10.1038/nri956
pmid: 12461568
82
M Swiecki, M Colonna. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol 2015; 15(8): 471–485 https://doi.org/10.1038/nri3865
pmid: 26160613
83
B Webster, S Assil, M Dreux. Cell-cell sensing of viral infection by plasmacytoid dendritic cells. J Virol 2016; 90(22): 10050–10053 https://doi.org/10.1128/JVI.01692-16
pmid: 27605675
84
O Dessouki, Y Kamiya, H Nagahama, M Tanaka, S Suzu, Y Sasaki, S Okada. Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: reversion by anti-viral treatment. Biochem Biophys Res Commun 2010; 393(2): 331–337 https://doi.org/10.1016/j.bbrc.2010.02.008
pmid: 20138830
85
M Jinushi, T Takehara, T Tatsumi, T Kanto, V Groh, T Spies, T Suzuki, T Miyagi, N Hayashi. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol 2003; 171(10): 5423–5429 https://doi.org/10.4049/jimmunol.171.10.5423
pmid: 14607946
86
R Kiessling, E Klein, H Wigzell. “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975; 5(2): 112–117 https://doi.org/10.1002/eji.1830050208
pmid: 1234049
87
Q Hammer, T Rückert, C Romagnani. Natural killer cell specificity for viral infections. Nat Immunol 2018; 19(8): 800–808 doi:10.1038/s41590-018-0163-6
pmid: 30026479
88
LM Kronstad, C Seiler, R Vergara, SP Holmes, CA Blish. Differential induction of IFN-a and modulation of CD112 and CD54 expression govern the magnitude of NK cell IFN-g response to influenza A viruses. J Immunol 2018; 201(7): 2117–2131 https://doi.org/10.4049/jimmunol.1800161
pmid: 30143589
89
A Martín-Fontecha, LL Thomsen, S Brett, C Gerard, M Lipp, A Lanzavecchia, F Sallusto. Induced recruitment of NK cells to lymph nodes provides IFN-γ for T(H)1 priming. Nat Immunol 2004; 5(12): 1260–1265 https://doi.org/10.1038/ni1138
pmid: 15531883
90
HR Wagstaffe, CM Nielsen, EM Riley, MR Goodier. IL-15 promotes polyfunctional NK cell responses to influenza by boosting IL-12 production. J Immunol 2018; 200(8): 2738–2747 https://doi.org/10.4049/jimmunol.1701614
pmid: 29491009
91
AE Zamora, EG Aguilar, CM Sungur, LT Khuat, C Dunai, GR Lochhead, J Du, C Pomeroy, BR Blazar, DL Longo, JM Venstrom, N Baumgarth, WJ Murphy. Licensing delineates helper and effector NK cell subsets during viral infection. JCI Insight 2017; 2(10): e87032 https://doi.org/10.1172/jci.insight.87032
pmid: 28515356
92
E Vivier, E Tomasello, M Baratin, T Walzer, S Ugolini. Functions of natural killer cells. Nat Immunol 2008; 9(5): 503–510 https://doi.org/10.1038/ni1582
pmid: 18425107
93
LL Liu, J Landskron, EH Ask, M Enqvist, E Sohlberg, JA Traherne, Q Hammer, JP Goodridge, S Larsson, J Jayaraman, VYS Oei, M Schaffer, K Taskén, HG Ljunggren, C Romagnani, J Trowsdale, KJ Malmberg, V Béziat. Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans. Cell Reports 2016; 15(5): 1088–1099 https://doi.org/10.1016/j.celrep.2016.04.005
pmid: 27117418
94
M Luetke-Eversloh, Q Hammer, P Durek, K Nordström, G Gasparoni, M Pink, A Hamann, J Walter, HD Chang, J Dong, C Romagnani. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog 2014; 10(10): e1004441 https://doi.org/10.1371/journal.ppat.1004441
pmid: 25329659
95
KB Nguyen, TP Salazar-Mather, MY Dalod, JB Van Deusen, XQ Wei, FY Liew, MA Caligiuri, JE Durbin, CA Biron. Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002; 169(8): 4279–4287 https://doi.org/10.4049/jimmunol.169.8.4279
pmid: 12370359
96
S Madera, M Rapp, MA Firth, JN Beilke, LL Lanier, JC Sun. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. J Exp Med 2016; 213(2): 225–233 https://doi.org/10.1084/jem.20150712
pmid: 26755706
97
DM Strauss-Albee, J Fukuyama, EC Liang, Y Yao, JA Jarrell, AL Drake, J Kinuthia, RR Montgomery, G John-Stewart, S Holmes, CA Blish. Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility. Sci Transl Med 2015; 7(297): 297ra115 https://doi.org/10.1126/scitranslmed.aac5722
pmid: 26203083
J Glienke, Y Sobanov, C Brostjan, C Steffens, C Nguyen, H Lehrach, E Hofer, F Francis. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics 1998; 48(3): 163–173 https://doi.org/10.1007/s002510050420
pmid: 9683661
100
E Hatjiharissi, L Xu, DD Santos, ZR Hunter, BT Ciccarelli, S Verselis, M Modica, Y Cao, RJ Manning, X Leleu, EA Dimmock, A Kortsaris, C Mitsiades, KC Anderson, EA Fox, SP Treon. Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcγRIIIa-158 V/V and V/F polymorphism. Blood 2007; 110(7): 2561–2564 https://doi.org/10.1182/blood-2007-01-070656
pmid: 17475906
101
S Sivori, S Parolini, E Marcenaro, R Millo, C Bottino, A Moretta. Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines. Hum Immunol 2000; 61(11): 1055–1058 https://doi.org/10.1016/S0198-8859(00)00201-9
pmid: 11137207
102
HT Hsu, EM Mace, AF Carisey, DI Viswanath, AE Christakou, M Wiklund, B Önfelt, JS Orange. NK cells converge lytic granules to promote cytotoxicity and prevent bystander killing. J Cell Biol 2016; 215(6): 875–889 https://doi.org/10.1083/jcb.201604136
pmid: 27903610
E Wong, RH Xu, D Rubio, A Lev, C Stotesbury, M Fang, LJ Sigal. Migratory dendritic cells, group 1 innate lymphoid cells, and inflammatory monocytes collaborate to recruit NK cells to the virus-infected lymph node. Cell Reports 2018; 24(1): 142–154 https://doi.org/10.1016/j.celrep.2018.06.004
pmid: 29972776
S McQuaid, S Loughran, P Power, P Maguire, D Walls, MG Cusi, C Orvell, P Johnson. Haemagglutinin-neuraminidase from HPIV3 mediates human NK regulation of T cell proliferation via NKp44 and NKp46. J Gen Virol 2018; 99(6): 763–767 https://doi.org/10.1099/jgv.0.001070
pmid: 29683419
108
M Mendelson, Y Tekoah, A Zilka, O Gershoni-Yahalom, R Gazit, H Achdout, NV Bovin, T Meningher, M Mandelboim, O Mandelboim, A David, A Porgador. NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J Virol 2010; 84(8): 3789–3797 https://doi.org/10.1128/JVI.01815-09
pmid: 20147410
109
M Diab, A Glasner, B Isaacson, Y Bar-On, Y Drori, R Yamin, A Duev-Cohen, O Danziger, R Zamostiano, M Mandelboim, S Jonjic, E Bacharach, O Mandelboim. NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection. Eur J Immunol 2017; 47(4): 692–703 https://doi.org/10.1002/eji.201646756
pmid: 28191644
110
Y Bar-On, Y Charpak-Amikam, A Glasner, B Isaacson, A Duev-Cohen, P Tsukerman, A Varvak, M Mandelboim, O Mandelboim. NKp46 recognizes the sigma1 protein of reovirus: implications for reovirus-based cancer therapy. J Virol 2017; 91(19): e01045-17 https://doi.org/10.1128/JVI.01045-17
pmid: 28724773
111
G Ahlenstiel, RH Titerence, C Koh, B Edlich, JJ Feld, Y Rotman, MG Ghany, JH Hoofnagle, TJ Liang, T Heller, B Rehermann. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-α-dependent manner. Gastroenterology 2010; 138: 325–335.e1–2 PMID: 19747917 https://doi.org/DOI: 10.1053/j.gastro.2009.08.066
112
V Béziat, O Dalgard, T Asselah, P Halfon, P Bedossa, A Boudifa, B Hervier, I Theodorou, M Martinot, P Debré, NK Björkström, KJ Malmberg, P Marcellin, V Vieillard. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol 2012; 42(2): 447–457 https://doi.org/10.1002/eji.201141826
pmid: 22105371
113
DFG Malone, S Lunemann, J Hengst, HG Ljunggren, MP Manns, JK Sandberg, M Cornberg, H Wedemeyer, NK Björkström. Cytomegalovirus-driven adaptive-like natural killer cell expansions are unaffected by concurrent chronic hepatitis virus infections. Front Immunol 2017; 8: 525 https://doi.org/10.3389/fimmu.2017.00525
pmid: 28533779
114
C Petitdemange, N Wauquier, H Devilliers, H Yssel, I Mombo, M Caron, D Nkoghé, P Debré, E Leroy, V Vieillard. Longitudinal analysis of natural killer cells in dengue virus-infected patients in comparison to Chikungunya and Chikungunya/Dengue virus-infected patients. PLoS Negl Trop Dis 2016; 10(3): e0004499 https://doi.org/10.1371/journal.pntd.0004499
pmid: 26938618
115
M Mittelbrunn, C Gutiérrez-Vázquez, C Villarroya-Beltri, S González, F Sánchez-Cabo, MA González, A Bernad, F Sánchez-Madrid. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2011; 2(1): 282 https://doi.org/10.1038/ncomms1285
pmid: 21505438
116
JS Schorey, CV Harding. Extracellular vesicles and infectious diseases: new complexity to an old story. J Clin Invest 2016; 126(4): 1181–1189 https://doi.org/10.1172/JCI81132
pmid: 27035809
117
K Tamai, N Tanaka, T Nakano, E Kakazu, Y Kondo, J Inoue, M Shiina, K Fukushima, T Hoshino, K Sano, Y Ueno, T Shimosegawa, K Sugamura. Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. Biochem Biophys Res Commun 2010; 399(3): 384–390 https://doi.org/10.1016/j.bbrc.2010.07.083
pmid: 20673754
MZ Ratajczak, J Ratajczak. Horizontal transfer of RNA and proteins between cells by extracellular microvesicles: 14 years later. Clin Transl Med 2016; 5(1): 7 https://doi.org/10.1186/s40169-016-0087-4
pmid: 26943717
120
A Schwab, SS Meyering, B Lepene, S Iordanskiy, ML van Hoek, RM Hakami, F Kashanchi. Extracellular vesicles from infected cells: potential for direct pathogenesis. Front Microbiol 2015; 6: 1132 https://doi.org/10.3389/fmicb.2015.01132
pmid: 26539170
121
K Takahashi, S Asabe, S Wieland, U Garaigorta, P Gastaminza, M Isogawa, FV Chisari. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci USA 2010; 107(16): 7431–7436 https://doi.org/10.1073/pnas.1002301107
pmid: 20231459
122
M Dreux, U Garaigorta, B Boyd, E Décembre, J Chung, C Whitten-Bauer, S Wieland, FV Chisari. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 2012; 12(4): 558–570 https://doi.org/10.1016/j.chom.2012.08.010
pmid: 23084922
123
X Liu, Z Zhang, J Ruan, Y Pan, VG Magupalli, H Wu, J Lieberman. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 2016; 535(7610): 153–158 https://doi.org/10.1038/nature18629
pmid: 27383986
124
A Lu, VG Magupalli, J Ruan, Q Yin, MK Atianand, MR Vos, GF Schröder, KA Fitzgerald, H Wu, EH Egelman. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 2014; 156(6): 1193–1206 https://doi.org/10.1016/j.cell.2014.02.008
pmid: 24630722
125
B Balci-Peynircioglu, AL Waite, P Schaner, ZE Taskiran, N Richards, D Orhan, S Gucer, S Ozen, D Gumucio, E Yilmaz. Expression of ASC in renal tissues of familial mediterranean fever patients with amyloidosis: postulating a role for ASC in AA type amyloid deposition. Exp Biol Med (Maywood) 2008; 233(11): 1324–1333 https://doi.org/10.3181/0803-RM-106
pmid: 18791131
126
A Baroja-Mazo, F Martín-Sánchez, AI Gomez, CM Martínez, J Amores-Iniesta, V Compan, M Barberà-Cremades, J Yagüe, E Ruiz-Ortiz, J Antón, S Buján, I Couillin, D Brough, JI Arostegui, P Pelegrín. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol 2014; 15(8): 738–748 https://doi.org/10.1038/ni.2919
pmid: 24952504
127
BS Franklin, L Bossaller, D De Nardo, JM Ratter, A Stutz, G Engels, C Brenker, M Nordhoff, SR Mirandola, A Al-Amoudi, MS Mangan, S Zimmer, BG Monks, M Fricke, RE Schmidt, T Espevik, B Jones, AG Jarnicki, PM Hansbro, P Busto, A Marshak-Rothstein, S Hornemann, A Aguzzi, W Kastenmüller, E Latz. The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat Immunol 2014; 15(8): 727–737 https://doi.org/10.1038/ni.2913
pmid: 24952505
128
HS Chahar, X Bao, A Casola. Exosomes and their role in the life cycle and pathogenesis of RNA viruses. Viruses 2015; 7(6): 3204–3225 https://doi.org/10.3390/v7062770
pmid: 26102580
129
G Birungi, SM Chen, BP Loy, ML Ng, SF Li. Metabolomics approach for investigation of effects of dengue virus infection using the EA.hy926 cell line. J Proteome Res 2010; 9(12): 6523–6534 https://doi.org/10.1021/pr100727m
pmid: 20954703
130
T Delgado, EL Sanchez, R Camarda, M Lagunoff. Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection. PLoS Pathog 2012; 8(8): e1002866 https://doi.org/10.1371/journal.ppat.1002866
pmid: 22916018
131
DL Diamond, AJ Syder, JM Jacobs, CM Sorensen, KA Walters, SC Proll, JE McDermott, MA Gritsenko, Q Zhang, R Zhao, TO Metz, DG Camp 2nd, KM Waters, RD Smith, CM Rice, MG Katze. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog 2010; 6(1): e1000719 https://doi.org/10.1371/journal.ppat.1000719
pmid: 20062526
132
KA Fontaine, R Camarda, M Lagunoff. Vaccinia virus requires glutamine but not glucose for efficient replication. J Virol 2014; 88(8): 4366–4374 https://doi.org/10.1128/JVI.03134-13
pmid: 24501408
133
KA Fontaine, EL Sanchez, R Camarda, M Lagunoff. Dengue virus induces and requires glycolysis for optimal replication. J Virol 2015; 89(4): 2358–2366 https://doi.org/10.1128/JVI.02309-14
pmid: 25505078
134
C Ramière, J Rodriguez, LS Enache, V Lotteau, P André, O Diaz. Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A. J Virol 2014; 88(6): 3246–3254 https://doi.org/10.1128/JVI.02862-13
pmid: 24390321
135
S Bandiera, S Pernot, H El Saghire, SC Durand, C Thumann, E Crouchet, T Ye, I Fofana, MA Oudot, J Barths, C Schuster, P Pessaux, MH Heim, TF Baumert, MB Zeisel. Hepatitis C virus-induced upregulation of microRNA miR-146a-5p in hepatocytes promotes viral infection and deregulates metabolic pathways associated with liver disease pathogenesis. J Virol 2016; 90(14): 6387–6400 https://doi.org/10.1128/JVI.00619-16
pmid: 27147737
BC Mounce, EZ Poirier, G Passoni, E Simon-Loriere, T Cesaro, M Prot, KA Stapleford, G Moratorio, A Sakuntabhai, JP Levraud, M Vignuzzi. Interferon-induced spermidine-spermine acetyltransferase and polyamine depletion restrict Zika and Chikungunya viruses. Cell Host Microbe 2016; 20(2): 167–177 https://doi.org/10.1016/j.chom.2016.06.011
pmid: 27427208
EU Uehara, BS Shida, CA de Brito. Role of nitric oxide in immune responses against viruses: beyond microbicidal activity. Inflamm Res 2015; 64(11): 845–852 https://doi.org/10.1007/s00011-015-0857-2
pmid: 26208702
141
M Colasanti, T Persichini, G Venturini, P Ascenzi. S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide. IUBMB Life 1999; 48(1): 25–31 https://doi.org/10.1080/713803459
pmid: 10791912
142
M Saura, C Zaragoza, A McMillan, RA Quick, C Hohenadl, JM Lowenstein, CJ Lowenstein. An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 1999; 10(1): 21–28 https://doi.org/10.1016/S1074-7613(00)80003-5
pmid: 10023767
A Dorhoi, V Yeremeev, G Nouailles, J Weiner 3rd, S Jörg, E Heinemann, D Oberbeck-Müller, JK Knaul, A Vogelzang, ST Reece, K Hahnke, HJ Mollenkopf, V Brinkmann, SH Kaufmann. Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics. Eur J Immunol 2014; 44(8): 2380–2393 https://doi.org/10.1002/eji.201344219
pmid: 24782112
145
Y Watanabe, O Suzuki, T Haruyama, T Akaike. Interferon-γ induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis. J Cell Biochem 2003; 89(2): 244–253 https://doi.org/10.1002/jcb.10501
pmid: 12704788
146
HY Yim, Y Yang, JS Lim, MS Lee, DE Zhang, KI Kim. The mitochondrial pathway and reactive oxygen species are critical contributors to interferon-a/b-mediated apoptosis in Ubp43-deficient hematopoietic cells. Biochem Biophys Res Commun 2012; 423(2): 436–440 https://doi.org/10.1016/j.bbrc.2012.05.154
pmid: 22683641
147
KS Burrack, TE Morrison. The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases. Front Immunol 2014; 5: 428 https://doi.org/10.3389/fimmu.2014.00428
pmid: 25250029
C Ptaschinski, S Mukherjee, ML Moore, M Albert, K Helin, SL Kunkel, NW Lukacs. RSV-induced H3K4 demethylase KDM5B leads to regulation of dendritic cell-derived innate cytokines and exacerbates pathogenesis in vivo. PLoS Pathog 2015; 11(6): e1004978 https://doi.org/10.1371/journal.ppat.1004978
pmid: 26083387
C Schliehe, EK Flynn, B Vilagos, U Richson, S Swaminanthan, B Bosnjak, L Bauer, RK Kandasamy, IM Griesshammer, L Kosack, F Schmitz, V Litvak, J Sissons, A Lercher, A Bhattacharya, K Khamina, AL Trivett, L Tessarollo, I Mesteri, A Hladik, D Merkler, S Kubicek, S Knapp, MM Epstein, DE Symer, A Aderem, A Bergthaler. The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat Immunol 2015; 16(1): 67–74 https://doi.org/10.1038/ni.3046
pmid: 25419628
152
J Yang, B Tian, H Sun, RP Garofalo, AR Brasier. Epigenetic silencing of IRF1 dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition. Nat Microbiol 2017; 2(8): 17086 https://doi.org/10.1038/nmicrobiol.2017.86
pmid: 28581456
153
M Meisel, R Hinterleitner, A Pacis, L Chen, ZM Earley, T Mayassi, JF Pierre, JD Ernest, HJ Galipeau, N Thuille, R Bouziat, M Buscarlet, DL Ringus, Y Wang, Y Li, V Dinh, SM Kim, BD McDonald, MA Zurenski, MW Musch, GC Furtado, SA Lira, G Baier, EB Chang, AM Eren, CR Weber, L Busque, LA Godley, EF Verdú, LB Barreiro, B Jabri. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 2018; 557(7706): 580–584 https://doi.org/10.1038/s41586-018-0125-z
pmid: 29769727
154
Q Zhang, K Zhao, Q Shen, Y Han, Y Gu, X Li, D Zhao, Y Liu, C Wang, X Zhang, X Su, J Liu, W Ge, RL Levine, N Li, X Cao. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 2015; 525(7569): 389–393 https://doi.org/10.1038/nature15252
pmid: 26287468